Association between graft function and serum TNF-α, TNFR1 and TNFR2 levels in patients with kidney transplantation

References

• Kocak H, Oner-Iyidogan Y, Gurdol F, Kocak T, Nane I, Genc S. Cystatin-C and creatinine as indices of glomerular filtration rate in the immediate follow-up of renal transplant patients. Clin Exp Med. 2005;5(1):14–19
   PubMed Web of Science ®Google Scholar
• Akbas SH, Yavuz A, Tuncer M, et al. Serum cystatin C as an index of renal function in kidney transplant patients. Transplant Proc. 2004;36(1):99–101
   PubMed Web of Science ®Google Scholar
• Lima JR, Salgado JV, Ferreira TC, Oliveira MI, Santos AM, Salgado Filho N. Cystatin C and inflammatory markers in kidney transplant recipients. Rev Assoc Med Bras. 2011;57(3):347–352
   PubMedGoogle Scholar
• Liu J. Evaluation of serum cystatin C for diagnosis of acute rejection after renal transplantation. Transplant Proc. 2012;44(5):1250–1253
   PubMed Web of Science ®Google Scholar
• Wang J, Al-Lamki RS. Tumor necrosis factor receptor 2: Its contribution to acute cellular rejection and clear cell renal carcinoma. Biomed Res Int. 2013; 2013;2013:Article ID 821310, 11 pages
   Google Scholar
• Fiers W. Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level. FEBS Lett. 1991;285(2):199–212
   PubMed Web of Science ®Google Scholar
• Rothe J, Gehr G, Loetscher H, Lesslauer W. Tumor necrosis factor receptors-structure and function. Immunol Res. 1992;11(2):81–90
   PubMed Web of Science ®Google Scholar
• Bradley JR, Thiru S, Pober JS. Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol. 1995;146(1):27–32
   PubMed Web of Science ®Google Scholar
• Speeckaert MM, Speeckaert R, Laute M, Vanholder R, Delanghe JR. Tumor necrosis factor receptors: Biology and therapeutic potential in kidney diseases. Am J Nephrol. 2012;36(3):261–270
   PubMed Web of Science ®Google Scholar
• Baud L, Ardaillou R. Tumor necrosis factor in renal injury. Miner Electrolyte Metab. 1995;21:336–341
   PubMedGoogle Scholar
• Morel D, Normand E, Lemoine C, et al. Tumor necrosis factor alpha in human kidney transplant rejection analysis by in situ hybridization. Transplantation. 1993;55(4):773–777
   PubMed Web of Science ®Google Scholar
• Al-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, Bradley JR. Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest. 2001;81(11):1503–1515
   PubMed Web of Science ®Google Scholar
• Sonkar GK, Singh S, Sonkar SK, Singh U, Singh RG. Evaluation of serum interleukin 6 and tumour necrosis factor alpha levels, and their association with various non-immunological parameters in renal transplant recipients. Singapore Med J. 2013;54(9):511–515
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150
   Web of Science ®Google Scholar
• Krishnamurthy N, Arumugasamy K, Anand U, Anand CV, Aruna V, Venu G. Serum cystatin C levels in renal transplant recipients. Indian J Clin Biochem. 2011;26(2):120–124
   Google Scholar
• Risch L, Blumberg A, Huber A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol Dial Transplant. 1999;14:1991–1996
   PubMed Web of Science ®Google Scholar
• Hoffmann U, Bergler T, Rihm M, et al. Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection. Am J Transplant. 2009;9(4):675–686
   PubMed Web of Science ®Google Scholar
• Wiggins MC, Bracher M, Mall A, Hickman R, Robson SC, Kahn D. Tumour necrosis factor levels during acute rejection and acute tubular necrosis in renal transplant recipients. Transpl Immunol. 2000;8(3):211–215
   PubMed Web of Science ®Google Scholar
• Joyce DA, Steer JH, Abraham LJ. Glucocorticoid modulation of human monocyte/macrophage function: Control of TNF-alpha secretion Inflamm Res. 1997;46(11):447–451
   PubMed Web of Science ®Google Scholar
• Halwachs G, Tiran A, Reisinger EC, et al. Serum levels of the soluble receptor for tumor necrosis factor in patients with renal disease. Clin Invest. 1994;72(6):473–476
   PubMedGoogle Scholar
• Lambert C, Berthoux P, Vindimian M, Hacini J, Berthoux F. Natural serum TNF antagonists in end-stage renal failure and following renal transplantation. Nephrol Dial Transplant. 1994;9(12):1791–1796
   PubMed Web of Science ®Google Scholar
• Diller R, Winde G, Kötting S, Senninger N, Dietl KH, Spiegel HU. sTNF-RII: Is it useful for the early diagnosis of rejection and for prognosis after renal transplantation? Transplant Int. 2002;15(7):335–340
   PubMed Web of Science ®Google Scholar
• Reinhold SW, Straub RH, Krüger B, et al. Elevated urinary sVCAM-1, IL6, sIL6R and TNFR1 concentrations indicate acute kidney transplant rejection in the first 2 weeks after transplantation. Cytokine. 2012;57(3):379–388
   PubMed Web of Science ®Google Scholar
• Keil M, Pec MK, Schenn G, et al. Value of serum soluble tumour necrosis factor concentrations in the diagnosis and prognosis of renal graft rejection. Nephrol Dial Transplant. 1994;9(7):815–819
   PubMed Web of Science ®Google Scholar